John,

Glyphosate, the main chemical ingredient in the pesticide Roundup, has been linked to cancer.1

After losing several high-profile court cases to plaintiffs who claimed the pesticide caused their cancer, Bayer, the maker of Roundup, announced it would replace the pesticide with glyphosate-free formulations starting in 2023.2

But that announcement was back in 2021, and glyphosate-containing Roundup is still for sale to consumers in the U.S.

Tell Bayer: Reformulate Roundup without glyphosate or any other toxic, dangerous ingredients this year.

In 2015, the cancer research arm of the World Health Organization determined glyphosate is "probably carcinogenic to humans."3

Since then, Monsanto, the original maker of Roundup, has settled more than 100,000 lawsuits filed by people who claimed the pesticide caused their cancer, paying out $11 billion as of May 2022. A high-profile case in 2018 awarded a California school groundskeeper nearly $300 million in damages (later reduced to $78 million) after he developed terminal non-Hodgkin's lymphoma following years of repeated exposure to Roundup.4,5

Now Roundup's current owner, Bayer, has committed to replacing glyphosate-based Roundup with new formulations using different active ingredients.6 But you can still find glyphosate-based Roundup for sale in garden centers.

Roundup is the most popular weed killer ever sold.7 The longer Bayer waits to remove glyphosate, the more of this dangerous chemical will be applied to lawns, gardens and parks.

We can't wait any longer. Tell Bayer to remove glyphosate now and reformulate Roundup without any other dangerous ingredients.

Thank you,

Faye Park
President

1. "IARC Monograph on Glyphosate," International Agency for Research on Cancer, last accessed July 26, 2023.
2. Mari Gaines, "Roundup Lawsuit Update July 2023," Forbes, May 23, 2023.
3. "IARC Monograph on Glyphosate," International Agency for Research on Cancer, last accessed July 26, 2023.
4. Mari Gaines, "Roundup Lawsuit Update July 2023," Forbes, May 23, 2023.
5. Holly Yan, "Cancer patient who was awarded $289 million in Monsanto trial says he'll take $78 million instead," CNN, November 1, 2018.
6. Mari Gaines, "Roundup Lawsuit Update July 2023," Forbes, May 23, 2023.
7. Mari Gaines, "Roundup Lawsuit Update July 2023," Forbes, May 23, 2023.

Support U.S. PIRG. Contributions by people just like you make our advocacy possible. Your contribution supports a staff of organizers, attorneys, scientists and other professionals who monitor government and corporate decisions and advocate on the public's behalf.

Join us on Facebook | Follow us on Twitter

U.S. PIRG, Main Office: 1543 Wazee St., Suite 460, Denver, CO 80202, (303) 801-0582
Federal Advocacy Office: 600 Pennsylvania Ave. SE, 4th Fl., Washington, DC 20003, (202) 546-9707
Member Questions or Requests: 1-800-838-6554.

If you want us to stop sending you email then follow this link -- unsubscribe.